Home › Oropharyngeal Cancer › District of Columbia › Washington
Oropharyngeal Cancer clinical trials in Washington, DC
4 studies for Oropharyngeal Cancer are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- George Washington University Medical Center, Washington D.C.
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
Recruiting
- Medstar Georgetown University Hospital, Washington D.C.
De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
RecruitingHealthy volunteers welcome
- Medstar Georgetown University Hospital, Washington D.C.
Oropharyngeal Cancer trials in other cities
- Atlanta, GA8 studies
- Edison, NJ8 studies
- Chicago, IL7 studies
- New York City, NY6 studies
- Queens, NY5 studies
- St. Louis, MO5 studies
- Kansas City, MO5 studies
- Tampa, FL5 studies
- Pittsburgh, PA5 studies
- Philadelphia, PA5 studies
- Omaha, NE5 studies
- Milwaukee, WI5 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.